![]() |
市場調查報告書
商品編碼
1351498
手持式手術器械市場規模 - 按產品(鑷子、牽開器、抓握器、手術刀、插管)、按應用(骨科手術、心臟病學、眼科、傷口護理、泌尿科和婦科手術)、按最終用途和預測,2023 年- 2032Hand-held Surgical Instruments Market Size - By Product (Forceps, Retractors, Graspers, Scalpels, Cannulas), By Application (Orthopedic Surgery, Cardiology, Ophthalmology, Wound Care, Urology & Gynecology Surgery), By End-use, & Forecast, 2023 - 2032 |
由於全球老年人口不斷增加,對外科手術的需求增加,全球手持手術器械市場在2023年至2032年期間複合年成長率將達到7.4%。
根據世界衛生組織估計,到2030 年,全球六分之一的人口將達到60 歲及以上。由於老年人經常需要醫療干預來解決各種健康問題,人口的成長對手部等醫療設備產生了強勁的需求。- 持有手術器械。此外,新興經濟體不斷擴大的醫療保健基礎設施以及民眾對醫療保健選擇的意識不斷增強,正在促進更多人獲得外科手術,進一步推動市場成長。 COVID-19 大流行也強調了醫療保健準備的重要性,促使醫療機構投資購買最先進的手術設備,包括手持器械,以滿足緊急醫療需求。
整個手持式手術器械市場根據產品、應用、最終用途和地區進行分類。
由於微創手術技術的日益普及,到 2032 年,擴張器產品領域的複合年成長率將達到 7.7%。這些器械在各種手術過程中擴張血管、組織或狹窄解剖結構、促進手術進入和減少組織創傷方面發揮著至關重要的作用。隨著患者偏好轉向微創治療和更快的恢復時間,對精確、高效的手持式擴張器的需求激增。
2023年至2032年,整形外科應用領域的複合年成長率將達8.3%。這是由於全世界越來越重視整容手術。整形外科醫生在整容、隆乳和隆鼻等手術中需要專門的儀器來進行精確和精細的組織操作。此外,材料和人體工學設計的創新正在提高外科醫生的能力和成果,從而促進整形外科領域的需求增加。
根據最終用途,由於門診和門診護理環境的成長趨勢,診所部分在 2023 年至 2032 年間將呈現 6.8% 的複合年成長率。診所擴大在現場進行各種小型外科手術,為患者提供更方便且更具成本效益的選擇。這些程序通常需要專門的手持式儀器來精確有效地執行,導致需求不斷成長。此外,向基於價值的醫療保健模式的轉變正在鼓勵診所投資高品質的儀器,這些儀器可以改善患者的治療效果並降低整體護理成本,從而進一步推動診所的需求。
從地區來看,到2032 年,亞太地區手持式手術器材產業的複合年成長率將達到8.5%。蓬勃發展的醫療旅遊業是一個重要推動因素,來自世界各地的患者在印度、泰國等國家尋求負擔得起的高品質手術治療和馬來西亞。此外,該地區與生活方式相關的疾病(例如肥胖症和糖尿病)日益流行,也提高了手術干預率。中國和印度等國家先進醫療技術的採用和醫療基礎設施的擴張也是推動亞太地區市場成長的關鍵因素。
Global hand-held surgical instruments market will record a 7.4% CAGR between 2023-2032, owing to the rising global geriatric population which is increasing the demand for surgical procedures.
According to estimates from the WHO, one out of six people worldwide will be aged 60 years and over by 2030. As elderly individuals often require medical interventions for various health issues, this increase in population is creating a strong demand for medical equipment such as hand-held surgical instruments. Additionally, the expanding healthcare infrastructure in emerging economies and the growing awareness of healthcare options among the populace are fostering greater access to surgical procedures, further propelling market growth. The COVID-19 pandemic has also underscored the importance of healthcare preparedness, prompting healthcare facilities to invest in state-of-the-art surgical equipment, including hand-held instruments, to address urgent medical needs.
The overall hand-held surgical instruments market is divided based on product, application, end-use, and region.
The dilators product segment will register a 7.7% CAGR through 2032, due to the growing prevalence of minimally invasive surgical techniques. These instruments play a crucial role in dilating blood vessels, tissues, or narrow anatomical structures during various procedures, facilitating access and reducing tissue trauma. As patient preferences shift towards less invasive treatments with quicker recovery times, the need for precise and efficient hand-held dilators has surged.
The plastic surgery application segment will record an 8.3% CAGR over 2023-2032. This is due to the growing emphasis on cosmetic procedures worldwide. Plastic surgeons require specialized instruments for precision and delicate tissue manipulation during surgeries like facelifts, breast augmentation, and rhinoplasties. Moreover, innovations in materials and ergonomic designs are enhancing surgeons' abilities and outcomes, contributing to the heightened demand in the field of plastic surgery.
Based on end-use, the clinics segment will exhibit a 6.8% CAGR between 2023-2032, due to the growing trend towards outpatient and ambulatory care settings. Clinics are increasingly performing a wide range of minor surgical procedures on-site to offer patients more convenient and cost-effective options. These procedures often require specialized hand-held instruments for precise and efficient execution, contributing to the rising demand. Furthermore, the shift towards value-based healthcare models is encouraging clinics to invest in high-quality instruments that can enhance patient outcomes and reduce the overall cost of care, further driving demand in clinic settings.
Regionally, the Asia Pacific hand-held surgical instruments industry will witness an 8.5% CAGR through 2032. One significant driver is the burgeoning medical tourism industry, with patients from around the world seeking affordable and high-quality surgical treatments in countries like India, Thailand, and Malaysia. Additionally, the increasing prevalence of lifestyle-related diseases in this region, such as obesity and diabetes, is boosting surgical intervention rates. The adoption of advanced healthcare technologies and the expansion of healthcare infrastructure in countries like China and India are also pivotal factors driving the market's growth in the Asia Pacific.